Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries

Vaccine

Volumn 17, Issue 18, 1999, Pages 2207-2222

  Bresee, Joseph S ^a   Glass, Roger I ^a   Ivanoff, Bernard ^b   Gentsch, Jon R ^a  

^a Viral Gastroenteritis Section   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VIRUS VACCINE; LIVE VACCINE; ROTAVIRUS VACCINE; SIMIAN ROTAVIRUS VACCINE;

CHILD; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DIARRHEA; DRUG COST; DRUG EFFICACY; DRUG SCREENING; DRUG SURVEILLANCE PROGRAM; HEALTH PROGRAM; HUMAN; HUMAN ROTAVIRUS; INFECTION CONTROL; NONHUMAN; ORAL DRUG ADMINISTRATION; PARENTERAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; VACCINATION; VACCINE PRODUCTION; VIRUS ATTENUATION; WORLD HEALTH ORGANIZATION;

DEVELOPING COUNTRIES; IMMUNIZATION PROGRAMS; PROGRAM EVALUATION; ROTAVIRUS; VIRAL VACCINES;

EID: 0033522521     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00376-4     Document Type: Review

References (148)

1. de Zoysa I., Feachem R.V. Interventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunization. Bull WHO. 63:1985;569-583.
2. Institute of Medicine. The prospects of immunizing against rotavirus. In: New vaccine development: diseases of importance in developing countries, vol. 2. Washington, DC: National Academy Press, 1986. p. D-13-2.
3. Rodriguez W.J., Kim H.W., Arrobio J.O.et al. Clinical features of acute gastroenteritis associated with human reovirus-like agent in infants and young children. J Pediatr. 91:1977;188-193.
4. Mata L., Simhon A., Padilla R., Gamboa MdM., Vargas G., Hernandez F., Mohs E., Lizano C. Diarrhea associated with rotaviruses, enterotoxigenic Escherichia coli, Campylobacter and other agents in Costa Rican children, 1976-1981. Am J Trop Med Hyg. 32:1983;146-153.
5. Zaki A.M., DuPont H.L., El Alamy M.A., Arafat R.R., Amin K., Awad M.M., Bassiouni L., Imam I.Z., El Malih G.S., El Marsafie A., Moheildin M.S., Naguib T., Rakha M.E., Sidaros M., Wasef N., Wright C.E., Wyatt R.E. The detection of enteropathogens in acute diarrhea in a family cohort population in a rural Egypt. Am J Trop Med Hyg. 35:1986;1013-1022.
6. Linhares A.C. Acute diarrhea associated with rotavirus among children in Belem, Brazil. Trans R Soc Trop Med Hyg. 77:1983;384-390.
7. Bass DM, Greenberg HB. Group A rotaviruses. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrnat RL, editors. Infections of the gastrointestinal tract. New York: Raven Press, 1995. p. 967-81.
8. Wyatt R.G., Yolken R.H., Urrutia J.J.et al. Diarrhea associated with rotavirus in rural Guatemala: a longitudinal study of 24 infants and young children. Am J Trop Med Hyg. 28:1979;325-328.
9. Black R.E., Lopez de Romana G., Brown K.H., Bravo N., Bazalar O.G., Kanashiro H.C. Incidence and etiology of infantile diarrhea and major routes of transmission in Huascar, Peru. Am J Epidemiol. 129:1989;785-799.
10. Mata L., Simhon A., Urrutia J.J., Kronmal R.A., Fernandez R., Garcia B. Epidemiology of rotaviruses in a cohort of 45 Guatamalan Mayan Indian children observed from birth to the age of three years. J Infect Dis. 148:1983;452-461.
11. Black R.E., Brown K.H., Becker S., Abdul Alim A.R.M., Huq I. Longitudinal studies of infectious diseases and physical growth of children in rural Bangaldesh. II. Incidence of diarrhea and association with known pathogens. Am J Epidemiol. 115:1982;315-324.
12. Abiodun P.O., Ihongbe J.C., Ogbimi A. Asymptomatic rotavirus infection in Nigerian day-care centres. Ann Trop Paediatr. 5:1985;163-165.
13. Araya M., Figueroa G., Espinoza J., Zarur X., Brunser O. Acute diarrhoea and asymptomatic infection in Chilean preschoolers of low and high socio-economic strata. Acta Paediatr Scand. 75:1986;645-651.
14. Champsaur H., Questiaux E., Prevot J., Henry-Amar M., Goldszmidt D., Bourjouane M., Bach C. Rotavirus carriage, asymptomatic infection and desease in the first two years of life. I. Virus shedding. J Infect Dis. 149:1984;667-674.
15. Losonsky G.A., Reymann M. The immune response in primary asymptomatic and symptomatic rotavirus infection in newborn infants. J Infect Dis. 161:1990;330-332.
16. Schorling J.B., Wanke C.A., Schorling S.K., McAuliffe J.F., Auxiliadora de Souza M., Guerrant R.L. A prospective study of persistent diarrhea among children in an urban Brazilian slum. Am J Epidemiol. 132:1990;144-156.
17. Cravioto A., Reyes R.E., Trujillo F., Uribe F., Navarro A., De La Roca J.M., Hernandez J.M., Perez G., Vazquez V. Risk of diarrhea during the first year of life associated with initial and subsequent colonization by specific enteropathogens. Am J Epidemiol. 131:1990;886-904.
18. Georges-Courbot M.C., Monges J., Beraud-Cassel A.M., Gouandjika I., Georges A.J. Prospective longitudinal study of rotavirus infection in children from birth to two years in Central Africa. Ann Inst Pasteur Virol. 139:1988;421-428.
19. Linhares A.C., Gabbay Y.B., Freitas R.B., da Rosa E.S., Mascarenhas J.D., Loureiro E.C. Longitudinal study of rotavirus infections among children from Belem, Brazil. Epidemiol Infect. 102:1989;129-145.
20. Simhon A., Mata L., Vives M., Rivera L., Vargas S., Ramirez G., Lizano L., Catarinella G., Azofeifa J. Low endemicity and low pathogenicity of rotaviruses among rural children in Costa Rica. J Infect Dis. 152:1985;1134-1142.
21. Black R.E., Greenberg H.B., Kapikian A.Z., Brown K.H., Becker S. Acquisition of serum antibody to Norwalk virus and rotavirus and relation to diarrhea in a longitudinal study of young children in rural Bangladesh. J Infect Dis. 145:1982;483-489.
22. Rodriguez W.J., Kim H.W., Brandt C.D.et al. Fecal adenoviruses from a longitudinal study of failies in metropolitan Washington, DC: laboratory, clinical, and epidemiologic observations. J Pediatr. 107:1985;514-520.
23. Brandt C.D., Kim H.W., Rodriguez J.O., Arrobio W.J., Jeffries B.C., Stallings E.P., Lewis C., Miles A.J., Chanock R.M., Kapikian A.Z., Parrott R.H. Pediatric viral gastroenteritis during eight years of study. J Clin Microbiol. 18:1983;71-78.
24. Bhan M.K., Raj P., Bhandari N., Svensson L., Stintzing G., Prasad A.K., Jayashree S., Srivatsava R. Role of enteric adenoviruses and rotaviruses in mild and severe acute enteritis. Pediatr Infect Dis J. 7:1988;320-323.
25. Kapikian AZ, Chanock RM. Rotaviruses. In: Fields BN, Knipe DM, Chanock RM, Hirsch MS, Melnick JL, Monath TP, Roizman B, editors. Virology, vol. 2. 2nd ed. New York: Raven Press, 1990. p. 1353-404.
26. Grinstein S., Gomez J.A., Bercovich J.A., Biscotti E.L. Epidemiology of rotavirus infection and gastroenteritis in prospectively monitored Argentine families with young children. Am J Epidemiol. 130:1989;300-308.
27. Reves R.R., Hossain M.M., Midthun K., Kapikian A.Z., Naguib T., Zaki A.M., DuPont H.L. An observational study of naturally acquired immunity to rotaviral diarrhea in a cohort of 363 Egyptian children. Am J Epidemiol. 130:1989;981-988.
28. Velazquez F.R., Calva J.J., Guerrero M.L., Mass D., Glass R.I., Pickering L.K., Ruiz-Palacios G.M. Cohort study of rotavirus serotype patterns in symptomatic and asymptomatic infections in Mexican children. Pediatr Infect Dis J. 12:1993;54-61.
29. Cook S.M., Glass R.I., LeBaron C.W., Ho M.-S. Global seasonality of rotavirus infections. Bull WHO. 68:1990;171-177.
30. Spencer H.C.et al. Diarrhea in non-hospitalized rural Salvadoran population: the role of enterotoxigenic Escherichia coli and rotavirus. Am J Trop Med Hyg. 29:1980;246-253.
31. Oyejude C.O., Fagbami A.H. An epidemiological study of rotavirus diarrhoea in a cohort of Nigerian infants. II. Incidence of diarrhoea in the first two years of life. Int J Epidemiol. 17:1988;908-912.
32. Guerrant R.L., Kirchoff L.V., Shields D.S., Nations M.K., Leslie J., de Sousa M.A., Araujo J.G., Carreia L.L., Sauer K.T., McClelland K.E., Trowbridge F.L., Hughes J.M. Prospective study of diarrheal illnesses in Northeastern Brazil; patterns of disease, nutritional impact, etiologies and risk factors. J Infect Dis. 148:1983;986-997.
33. Sircar B.K., Deb B.C., Sengupta P.G., Mondal S., De S.P., Sen D., Saha M.R., Ghosh S.S., Sikdar S.N., Pal S.C. A longitudinal study of diarrhoea among children in Calcutta communities. Indian J Med Res. 80:1984;546-550.
34. Espejo R.T. Presence of two distinct types of rotavirus in infants and young children hospitalized with acute gastroenteritis in Mexico City. J Infect Dis. 139:1979;474-477.
35. Konno T., Suzuki H., Kutsushima N. Influence of temperature and relative humidity on juman rotavirus infection in Japan. J Infect Dis. 147:1983;125-128.
36. Rowland S.G.J.G., Lloyd-Evans N., Williams K., Rowland M.G.M. The etiology of diarrhoea studies in the community in young urban Gambian children. J Diarrhoeal Dis Res. 3:1985;7-13.
37. Cravioto A., Reyes R.E., Ortega R., Fernandez G., Hernandez R., Lopez D. Prospective study of diarrhoeal disease in a cohort of rural Mexican children: incidence and isolated pathogens during the first two years of life. Epidemiol Infect. 101:1988;123-134.
38. Hieber J.P. Comparison of human rotavirus disease in tropical and temperate settings. Am J Dis Children. 132:1978;853-858.
39. World Health Organisation. Investing in health research and development. Ad hoc committee on health research relating to future intervention options. Document TDR/Gen/96.1. Geneva: WHO, 1996. p. 19-33.
40. Snyder J.D., Merson M.H. The magnitude of the global problem of acute diarrhoeal disease: a review of active surveillance data. Bull WHO. 60:1982;605-613.
41. Bern C., Martines J., de Zoysa I., Glass R.I. The magnitude of the global problem of diarrhoeal disease: a ten year update. Bull WHO. 70:1992;705-714.
42. Murray C.J.L., Lopez A.D. Global and regional cause-of-death patterns in 1990. Bull WHO. 72:1994;447-480.
43. Anonymous. World population prospects. New York: United Nations.
44. Bishop R.F., Davidson G.P., Holmes I.H., Ruck B.J. Detection of a new virus by electron microscopy of fecal extracts from children with acute gastroenteritis. Lancet. 1:1974;149-151.
45. Estes MK. Rotaviruses and their replication. In: Fields BN, Knipe, DM, Howley, PM, editors. Virology. 3rd ed. New York: Raven Press, 1996. p. 1625-55.
46. Gentsch JR, Woods PA, Ramaschandran M, Das BK, Leite JP, Alfieri A, Kumar R, Bhan MK, Glass RI. Review of G and P typing results from a global collection of rotavirus strains: implication for vaccine development. J Infect Dis 1996;174:S30 - 36.
47. Timenetsky M. do C., Santos N., Gouvea V. Survey of rotavirus G and P types associated with human gastroenteritis in Sao Paulo, Brazil, from 1986 to 1992. J Clin Microbiol. 32:1994;2622-2624.
48. Ramachandran M., Das B.K., Vij A., Kumar R., Bhambal S.S., Kesari N., Rawat H., Bahl L., Thakur S., Woods P.A., Glass R.I., Bhan M.K., Gentsch J.R. Unusual diversity of human rotavirus G and P genotypes in India. J Clin Microbiol. 34:1996;436-439.
49. Ball J.M., Tian P., Zeng C.Q.-Y., Morris A.P., Estes M.K. Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science. 272:1996;101-104.
50. Burns J.W., Siadat-Pajoub M, Krishnaney A.A, Greenberg M.B. Protective effect of rotavirus VP-6-specific IgA monoclonal antibodies that lack neutralising activity. Science. 272:1996;7-104.
51. Bishop R.F, Barnes G.L, Cipricni E, Lund J.S Clinical immunity after neonatal rotavirus infection: a prospective longtitudinal study in young children. N Engl J Med. 309:1983;6-72.
52. Bhan M.K., Lew J.F., Sazawal S., Das B.K., Gentsch J.R., Glass R.I. Protection conferred by neonatal rotavirus infection against subsequent diarrhea. J Infect Dis. 168:1993;282-287.
53. Ward R.L., Bernstein D.I., U.S Rotavirus Vaccine Efficacy Group Protection against rotavirus disease after natural rotavirus infection. J Infect Dis. 169:1994;900-904.
54. Ward R.L. Mechanisms of protection against rotavirus in human and mice. J Infect Dis. 174 (Suppl.):1996;S51-S58.
55. Ward R.L., Knowlton D.R., Zito E.T., Davidson B.L., Rappaport R., Mack M.E., U.S Rotavirus Efficacy Group Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. J Infect Dis. 176:1997;570-577.
56. Clark H.F., Borian F.E., Plotkin S.A. Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC-3. J Infect Dis. 161:1990;1099-1104.
57. Bernstein D.I., Smith V.E., Sander D.S., Pax K.A., Schiff G.M., Ward R.L. Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis. 162:1990;1055-1062.
58. Kapikian A.Z., Greenberg H.B., Cline W.L., Kalica A.R., Wyatt R.G., James H.D.J., Lloyd N.L., Chanock R.M., Ryder R.W., Kim H.W. Prevalence of antibody to Norwalk agent by a newly developed immune adherence haemagglutination assay. J Med Virol. 2:1978;281-294.
59. Yolken R.H., Wyatt R.G., Zissiz G.et al. Epidemiology of human rotavirus types 1 and 2 as studied by enzyme-linked immunosorbent assay. N Engl J Med. 299:1978;1156-1161.
60. Biritwum R.B., Isomura S., Yamaguchi H., Toba M., Mingle J.A.A. Seroepidemiologic study of rotavirus infection in rural Ghana. Ann Trop Paediatr. 4:1984;237-240.
61. Rodriguez W.J., Kim H.W., Brandt C.D., Schwartz R.H., Gardner M.K., Jeffries B., Parrott R.H., Kaslow R.A., Smith J.I., Kapikian A.Z. Longitudinal study of rotavirus infection and gastroenteritis in families served by a pediatric medical practice: clinical and epidemiologic observations. Pediatr Infect Dis. 6:1987;170-176.
62. Gurwith M., Wenman W., Hinde D., Feltham S., Greenberg H. A prospective study of rotavirus infection in infants and young children. J Infect Dis. 144:1981;218-224.
63. Parashar UD, Holman RL, Clarke MJ, Bresee JS, Glass RI. Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1997: surveillance based on new ICD-9-CM rotavirus-specific diagnostic code. J Infect Dis 1997;177:13-7.
64. Jin S., Kilgore P.K., Holman R.C., Clarke M.J., Gangarosa E.J., Glass R.I. Trends in hospitalizations for diarrhea in the United States 1979-1992: estimates of the morbidity associated with rotavirus. Pediatr Infect Dis J. 15:1996;397-404.
65. Ryan M.J., Ramsay M., Brown D., Gay N.J., Farrington C.P., Wall P.G. Hospital admission attributable to rotavirus infection in England and Wales. J Infect Dis. 174 (Suppl.):1996;S12-S18.
66. Ho M.-S., Glass R.I., Pinsky P.F., Anderson L.J. Rotavirus as a cause of diarrheal morbidity and mortality in the United States. J Infect Dis. 158:1988;1112-1116.
67. LeBaron C.W., Lew J., Glass R.I., Weber J.M., Ruiz-Palacios G.M.et al. Annual rotavirus epidemic patterns in North America: results of a five-year retrospective survey of 88 centers in Canada, Mexico and the United States. J Am Med Assoc. 264:1990;983-988.
68. Sukumaran M., Gowda K., Maiya P.P., Srinivas T., Kumar M.S., Aijaz S., Reddy R.R., Padilla L., Greenberg H.B., Roa C.D. Exclusive asymptomatic neonatal infections by humna rotavirus strains having subgroup I specificity and 'long' RNA electropherotype. Arch Virol. 126:1992;239-251.
69. Omoignerale A.I., Abiodun P.O. Nosocomial rotavirus infection in newborns. East African Med J. 72:1995;220-221.
70. Kilgore P.E., Unicomb L.E., Gentsch J.R., Albert M.J., McElroy C.A., Glass R.I. Neonatal rotavirus infection in Bangladesh: strain characterization and risk factors for nosocomial infection. Pediatr Infect Dis J. 15:1996;672-677.
71. Perez-Schael I., Daoud G., White L., Urbina G., Daoud N., Perez M., Flores J. Rotavirus shedding by newborn children. J Med Virol. 14:1984;127-136.
72. Cicirello H.G., Das B.K., Gupta A., Bhan M.K., Gentch J.R., Kumar R., Glass R.I. High prevalence or rotavirus infection among neonates born at hospitals in Dehli, India: predisposition of newborns for infection with unusual rotavirus. Pediatr Infect Dis J. 13:1994;720-724.
73. Hopkins R.S., Gaspard G.B., Williams Jr F.P., Karlin R.J., Cukor G., Blacklow N.R. A community waterborne gastroenteritis outbreak: evidence for rotavirus as the agent. Am J Publ Health. 74:1984;263-265.
74. Foster S.O., Palmer E.L., Gary J.G.W., Martin M.L., Herrmann K.L., Beasley P., Sampson J. Gastroenteritis due to rotavirus in an isolated Pacific island group: an epidemic of 3,439 cases. J Infect Dis. 141:1980;32-39.
75. Nakagomi O., Nakagomi T. Genetic diversity and similarity among mammalian rotaviruses in relation to interspecies transmission of rotavirus. Arch Virol. 120:1991;43-55.
76. Bern C., Unicomb L., Gentsch J.R., Banul N., Yunus M., Sack R.B., Glass R.I. Rotavirus diarrhea in Bangladeshi children: correlation of disease severity with serotypes. J Clin Microbiol. 30:1992;3234-3238.
77. Mphahlele M.J., Steele A.D. Relative frequency of human rotavirus VP4 (P) genotypes recovered over a ten-year period from South African children with diarrhea. J Med Virol. 47:1995;1-5.
78. Hoshino Y., Wyatt R.G., Flores J., Midthun K., Kapikian A.Z. Serotypic characterization of rotaviruses derived from asymptomatic human neonatal infections. J Clin Microbiol. 21:1985;425-430.
79. Dunn S.J., Greenberg H.B., Ward R.L., Nakagomi O., Burns J.W., Vo P.T., Pax K.A., Das M., Gowda K., Rao C.D. Serotype and genotypic characterization of human serotype 10 rotavirus from asymptomatic neonates. J Clin Microbiol. 31:1993;165-169.
80. Das B.K., Gentsch J.R., Cicirello H.G., Woods P.A., Ramachandran M., Gupta A., Ramachandran M., Kumar R., Bhan M.K., Glass R.I. Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol. 32:1994;1820-1822.
81. Sack D.A., Chowdury A.M.A.K., Eusof A., Ali M.A., Merson M.H., Islam R.E., Black R.E., Brown K.H. Oral hydration in rotavirus diarrhoea: a double blind comparison of sucrose with glucose electrolyte solution. Lancet. 2:1978;280-283.
82. Gurwith M., Wenman W., Gurwith D., Brunton J., Feltham S., Greenberg H. Diarrhea among infants and young children in Canada: a longitudinal study in three northern communities. J Infect Dis. 147:1983;685-692.
83. Glass R.I., Stoll B.J., Wyatt R.G., Hoshino Y., Banu H., Kapikian A.Z. Observations questioning a protective role for breast-feeding in severe rotavirus diarrhea. Acta Pediatr Scand. 75:1986;713-718.
84. Glass R.I., Stoll B.J. The protective effect of human milk against diarrhea. Acta Pediatr Scand. 351:1989;131-136.
85. Duffy L.C., Byers T.E., Riepenhoff-Talty M., La Scolea L.J., Zielezny M., Ogra P.L. The effects of infant feeding on rotavirus-induced gastroenteritis: a prospective study. Am J Publ Health. 76:1986;259-263.
86. Weinberg R.J., Tipton G., Klish W.J., Brown M.R. Effect of breast-feeding on morbidity in rotavirus gastroenteritis. Pediatrics. 74:1984;250-253.
87. Saulsbury F.T., Winkelstein J.A., Yolken R.H. Chronic rotavirus infection in immunodeficiency. J Pediatr. 97:1980;61-65.
88. Lososnky G.A., Johnson G.O., Winkelstein J.A., Yolken R.H. The oral administration of human serum immunoglobulin in immunodeficiency patients with viral gastroenteritis: a pharmocokinetic and functional analysis. J Clin Invest. 76:1985;2362-2367.
89. Ebina T., Sato A., Umezu K.et al. Prevention of rotavirus infection with cow colostrum containing antibody against human rotavirus. Lancet. 2:1983;1029-1030.
90. Hilpert H., Brussow H., Mietens C., Sidoti J., Lerner L., Werchau H. Use of bovine milk concentrate antibody to rotavirus to treat rotavirus gastroenteritis in infants. J Infect Dis. 156:1987;158-166.
91. Midthun K., Kapikian A.Z. Rotavirus vaccines: an overview. Clin Microbiol Rev. 9:1996;423-434.
92. Vesikari T., Isolauri E., Delem A., d'Hondt E., Andre F.E., Beards G.M., Flewett T.H. Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J Pediatr. 107:1985;189-194.
93. Vesikari T., Isolauri E., D'Hondt E. Protection of infants against rotavirus diarrhea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet. 1:1984;977-981.
94. Vesikari T., Ruuska T., Delem A., Andre F.E., Beards G.M., Flewett T.H. Efficacy of two doses of RIT 4237 bovine rotavirus vaccine (at birth and 7 months of age) for prevention of rotavirus diarrhea. Acta Paediatr Scand. 80:1991;173-180.
95. Hanlon P., Marsh V., Shenton F., Jobe O., Hayes R., Whittle H.C., Hanlon L., Byass P., Hassan-King M., Sillah H., M'Boge B.H., Greenwood B.M. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet. 1:1987;1342-1345.
96. Lanata C.F., Black R.E., del Aguila R., Verastegui H., Gerna G., Flores J., Kapikian A.Z., Andre F.E. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. J Infect Dis. 159:1989;452-459.
97. Santosham M., Letson W.G., Wolff M., Reid R., Gahagan S., Adams R., Callahan C., Sack R.S., Kapikian A.Z. A field study of the safety and efficacy of two candidate rotavirus vaccines in a native american population. J Infect Dis. 163:1991;483-487.
98. DeMol P., Zissis G., Butzler J.P., Mutwewingabo A., Andre F.E. Failure of live, attenuated oral rotavirus vaccine. Lancet. 1:1986;108.
99. Clark H.F., Borian F.E., Bell L.M., Plotkin S.A. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis. 158:1988;570-587.
100. Clark H.F., Offit P.A., Ellis R.W., Eiden J.J., Krah D., Shaw A.R., Pichichero M., Treanor J.J., Borian F.E., Bell L.M., Plotkin S.A. The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. J Infect Dis. 174 (Suppl.):1996;S73-S80.
101. Georges-Courbot M.C., Monges J., Siopathis M.R., Roungou J.B., Gresenguet G., Bellec L., Bouguety J.C., Lanckriet C., Cadoz M., Hessel L., Gouvea V., Clark F., Georges A.J. Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res Virol. 142:1991;405-411.
102. Gothefors L., Wadell G., Juto P., Taniguchi K., Kapikian A.Z., Glass R.I. Prolonged efficacy of rhesus rotavirus vaccine in Swedish children. J Infect Dis. 159:1989;753-757.
103. Rennels M.B., Kapikian A.Z. Preliminary evaluation of the efficacy of rhesus rotavirus vaccine strain MMU 18006 in young children. Pediatr Infect Dis J. 5:1986;587-588.
104. Christy C., Madore H.P., Pichichero M.E., Gala C., Pincus P., Vosefski D., Hoshino Y., Kapikian A., Dolin R. Field trial of rhesus rotavirus vaccine in infants. Pediatr Infect Dis J. 7:1988;645-650.
105. Rennels M.B., Losonsky G.A., Young A.E., Shindledecker C.L., Kapikian A.Z., Levine M.M. An efficacy trial of the rhesus rotavirus vaccine in Maryland. The clinical study group. Am J Dis Children. 144:1990;601-604.
106. Vesikari T., Rautenen T., Varis T., Beards G.M., Kapikian A.Z. Rhesus rotavirus candidate vaccine. Am J Dis Children. 144:1990;285-289.
107. Elmwood Panorama and Westfall Pediatric Groups, Madore H.P., Christy C., Pichichero M., Long C., Pincus P., Vosefsky D., Kapikian A.Z., Dolin R. Field trial of rhesus rotavirus or human-rhesus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. J Infect Dis. 166:1992;235-243.
108. Perez-Schael I., Garcia D., Gonzalez R., Daoud N., Perez M., Cunto W., Kapikian A.Z., Flores J. Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine. J Med Virol. 30:1990;219-229.
109. Vesikari T., Ruuska T., Green K.Y., Flores J., Kapikian A.Z. Protective efficacy against serotype 1 rotavirus diarrhea by livee oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity. Pediatr Infect Dis J. 11:1992;535-542.
110. Rennels M.B., Glass R.I., Dennehy P.H., Bernstein D.I., Pichichero M.E., Zito E.T., Mack M.E., Davidson B.L., Kapikian A.Z, U.S Rotavirus Vaccine Efficacy Group Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines-report of the national multicenter trial. Pediatrics. 97:1996;7-13.
111. U.S Rotavirus Vaccine Efficacy Group, Bernstein D.I., Glass R.I., Rodgers G., Davidson B.L., Sack D.A. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in U.S children. J Am Med Assoc. 273:1995;1191-1196.
112. Santosham M., Moulton L.H., Reid R., Croll J., Weatherholtz R., Ward R., Forro J., Zito E., Mack M., Brenneman G., Davidson B.L. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. J Pediatr. 131:1997;632-638.
113. Joensuu J., Koskenniemi E., Pang X.-L., Vesikari T. A randomized, double-blind, placebo controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet. 350:1997;1205-1209.
114. Lanata C.F., Midthun K., Black R.E., Butron B., Huapaya A., Penny M.E., Ventura G., Gil A., Jett-Goheen M., Davidson B.L. Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru. J Infect Dis. 174:1996;268-275.
115. Linhares A.C., Gabbay Y.B., Mascarenhas J.D.P., de Freitas R.B., Oliveira C.S., Bellisi N., Monteiro T.A.F., Lins-Lainson Z., Ramos F.L.P., Valente S.A. Immunogenicity, safety, and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belem, Brazil. Bull WHO. 74:1996;491-500.
116. Perez-Schael I., Guntinas M.J., Perez M., Pagone V., Rojas A.M., Gonzalez R., Cunto W., Hoshino Y., Kapikian A. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med. 337:1997;1181-1187.
117. Treanor J.J., Clark H.F., Pichichero M.et al. Evaluation of protective efficacy of a serotype 1 bovine-human reassortant rotavirus vaccine in infants. Pediatr Infect Dis J. 14:1995;301-307.
118. Christy C., Offit P., Clark H.F., Treanor J. Evaluation of a bovine-human rotavirus reassortant vaccine in infants. J Infect Dis. 168:1993;1598-1599.
119. Clark H.F., White C.J., Offit P.A.et al. Preliminary evaluation of safety and efficacy of quadrivalnet human-bovine rotavirus vaccine. Pediatr Res. 37:1995;172A.
120. Perez-Schael I., Blanco M., Garcia D., White L., Alfonzo E., Crespo I., Cunto W., Pittman A.L., Kapikian A.Z., Flores J. Evaluation of the antigenicity and reactinogenicity of varying formulations of the rhesus rotavirus-based quadrivalent and the M37 rotavirus vaccine candidates. J Med Virol. 42:1994;330-337.
121. Midthun K., Halsey N.A., Jett-Goheen M.et al. Safety and immunogenicity of human rotavirus vaccine strain M37 in adults, children and infants. J Infect Dis. 164:1991;792-796.
122. Vesikari T., Ruuska T., Koivu H., Green K.Y., Flores J., Kapikian A.Z. Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants. Pediatr Infect Dis J. 10:1991;912-917.
123. Bishop R.F., Hewstone A.S., Davidson G.P. An epidemic of diarrhea in human neonates involving a reoviruslike agent and 'enteropathogenic' serotypes of Escherichia coli. J Clin Pathol. 29:1976;46.
124. Das M., Dunn S.J., Woode G.N., Greenberg H.B., Rao C.D. Both surface proteins (VP4 and VP7) of an asymptomatic neonatal rotavirus strain (I321) have high levels of sequence identity with the homologous proteins of a serotype 10 bovine rotavirus. Virology. 194:1993;374-379.
125. Glass R.I., Bresee J.S., Ivanoff B. Rotavirus vaccines for developing countries. Weekly Epidemiol Rep. 6:1997;35-40.
126. Bai Z-S. Update on new vaccines. Consensus Workshop: rotavirus vaccines for the iummunization of children in developing countries, Geneva, 9-10 January 1997.
127. Connor M.E., Zarley C.D., Hu B., Parsons S., Drabinski D., Greiner S., Simth R., Jiang B., Barniak B., Modore H.P., Crawford S., Estes M.K. Virus-like particles as a rotavirus subunit vaccine. J Infect Dis. 174 (Suppl. 1):1996;S88-92.
128. Offit P.A., Khoury C.A., Moser C.A., Clark H.F., Kim J.E., Speaker T.J. Enhancement of rotavirus immunogenicity by microencapsulation. Virology. 203:1994;134-143.
129. Herrmann J.E., Chen S.C., Fynan E.F., Santoro J.C., Greenberg H.B., Wang S., Robinson H.L. Protection against rotavirus infections by DNA vaccination. J Infect Dis. 174 (Suppl. 1):1996;S93-97.
130. Kapikian A.Z., Hoshino Y., Chanock R.M., Perez-Schael I. Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. J Infect Dis. 174 (Suppl.):1996;S65-S72.
131. Kapikian AZ. Rhesus rotavirus-based human rotavirus vaccines and observations on selected non-Jennerian approaches to rotavirus vaccination. In: Kapikian AZ, editor. Viral infections of the gastrointestinal tract. 2nd ed. New York: Marcel Dekker, 1993. p. 443-70.
132. Moyenuddin M., Rahman K.Z., Sack D.A. The aetiology of diarrhoea in children at an urban hospital in Bangladesh. Trans R Soc Trop Med Hyg. 81:1987;299-302.
133. Leite J.P., Alfieri A.A.N.O., Woods P., Glass R.I., Gentsch J.R. Rotavirus G and P types circulating in Brazil: characterization by RT-PCR, probe hydridization, and sequence analysis. Arch Virol. 141:1996;2365-2374.
134. Chrystie I.L, Totterdell B.M, Banatvala J.E. Asymptomatic endemic rotavirus infections in the newborn. Lancet 1978;0:1176-1178.
135. Cunliffe NA, Kilgore PE, Bresee JS, Hart CA, Glass RI. Epidemiology of rotavirus diarrhea in Africa: a review of studies to antipate rotavirus vaccine. Bull WHO 1998;76:1 - 20.
136. Ruuska T., Vesikari T., Delem A., Andre F.E., Beards G.M., Flewett T.H. Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: correlation of vaccine efficacy and season of birth in relation to rotavirus epidemic period. Scand J Infect Dis. 22:1990;269-278.
137. Friedman M.G., Segal B., Zedaka R., Sarov B., Margalith M., Bishop R., Dagan R. Serum and salivary responses to oral tetravalent reassortant rotavirus vaccine in newborns. Clin Exp Immunol. 92:1993;194-199.
138. Pichichero M.E. Effect of breast-feeding on oral rhesus rotavirus vaccine seroconversion: a metaanalysis. J Infect Dis. 162:1990;753-755.
139. Glass R.I., Ing D.J., Stoll B.J.et al. Immune response to rotavirus vaccines among breast-fed and nonbreast-fed children. Adv Exp Biol Med. 310:1991;249-254.
140. Rennels M.B. Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines. J Infect Dis. 174 (Suppl.):1996;S107-S111.
141. Rennels M.B., Wasserman S.S., Glass R.I., Keane V.A, U.S Rotavirus Vaccine Efficacy Group Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breast-fed and non-breast-fed children in a large field setting. Pediatrics. 96:1995;1132-1136.
142. Migasena S., Simasathien S., Samakoses R., Pitisuttitham P., Sangaroon P., Steenis G.V., Beuvery E.C., Bugg H., Bishop R., Davidson B.L., Vesikari T. Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thailand. Vaccine. 13:1995;168-174.
143. Rennels M.B., Ward R.L., Mack M.E., Zito E.T, U.S Rotavirus Vaccine Efficacy Group Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. J Infect Dis. 173:1996;306-313.
144. Bartlett A.V., Moore M., Gary G.W., Starko K.M., Erben J.J., Meredith B.A. Diarrheal illness among infants and toddlers in day care centers. I. Epidemiology and pathogens. J Pediatr. 107:1985;495-502.
145. Clemens J., Brenner R., Rao M., Tafari N., Lowe C. Evaluating new vaccines for developing countries: efficacy or effectiveness? J Am Med Assoc. 275:1996;390-397.
146. Halloran M.E., Struchner C.J., Longini I.M. Study design for evaluation of differences in efficacy and effectiveness of vaccines. Am J Epidemiol. 146:1997;1-15.
147. Smith P.G., Rodrigues L.C., Fine P.E. Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol. 13:1984;87-93.
148. Murray C.J.L., Lopez A.D. Mortality by cause for eight regions of the world: global burden of disease study. Lancet. 349:1997;1269-1276.